Related Experiment Video
Updated: Mar 16, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes
Prakash C Deedwania1, Terje R Pedersen2, David A DeMicco3
1UCSF School of Medicine, Cardiology Division, Fresno, CA, USA.
Insights
High baseline systolic blood pressure (SBP) predicts stroke, while high low-density lipoprotein cholesterol (LDL-C) predicts coronary events in high-risk patients. These cardiovascular risk factors have differential impacts on vascular outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Epidemiology
Background:
- Cardiovascular disease (CVD) risk is elevated in patients with diabetes.
- Traditional risk factors like hypertension and dyslipidemia are key contributors to CVD.
- Investigating predictive values of baseline systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) is crucial for high-risk populations.
Purpose of the Study:
- To evaluate the predictive significance of baseline SBP and LDL-C for vascular outcomes.
- To analyze the differential impact of SBP and LDL-C on coronary events versus stroke.
- To assess these associations in a large cohort of patients at high risk for cardiovascular events, including a diabetic subgroup.
Main Methods:
- Pooled data from three large clinical trials: TNT, CARDS, and IDEAL, totaling 21,727 patients.
- Utilized multivariate Cox proportional-hazards models to assess the impact of baseline SBP and LDL-C.
- Analyzed cardiovascular events, coronary events, and stroke as primary outcomes.
Main Results:
- Higher baseline SBP and LDL-C were significantly associated with increased cardiovascular event risk overall.
- Baseline SBP predicted stroke risk, whereas higher LDL-C predicted coronary event risk.
- In the diabetic subgroup, baseline SBP did not predict coronary or stroke events, while LDL-C remained predictive of coronary events.
Conclusions:
- Baseline SBP and LDL-C are significant predictors of cardiovascular outcomes in high-risk individuals.
- The predictive value of these factors differs between cerebrovascular events (stroke) and coronary events.
- Findings highlight the distinct roles of blood pressure and cholesterol in different vascular territories.
Background:
Traditional cardiovascular risk factors, such as hypertension and dyslipidemia, predispose individuals to cardiovascular disease, particularly patients with diabetes. We investigated the predictive value of baseline systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) on the risk of vascular outcomes in a large population of patients at high risk of future cardiovascular events.
Methods:
Data were pooled from the TNT (Treating to New Targets), CARDS (Collaborative Atorvastatin Diabetes Study), and IDEAL (Incremental Decrease in End-Points Through Aggressive Lipid Lowering) trials and included a total of 21,727 patients (TNT: 10,001; CARDS: 2838; IDEAL: 8888). The effect of baseline SBP and LDL-C on cardiovascular events, coronary events, and stroke was evaluated using a multivariate Cox proportional-hazards model.
Results:
Overall, risk of cardiovascular events was significantly higher for patients with higher baseline SBP or LDL-C. Higher baseline SBP was significantly predictive of stroke but not coronary events. Conversely, higher baseline LDL-C was significantly predictive of coronary events but not stroke. Results from the subgroup with diabetes (5408 patients; TNT: 1501; CARDS: 2838; IDEAL: 1069) were broadly consistent with those of the total cohort: baseline SBP and LDL-C were significantly predictive of cardiovascular events overall, with the association to LDL-C predominantly related to an effect on coronary events. However, baseline SBP was not predictive of either coronary or stroke events in the pooled diabetic population.
Conclusions:
In this cohort of high-risk patients, baseline SBP and LDL-C were significantly predictive of cardiovascular outcomes, but this effect may differ between the cerebrovascular and coronary systems.
Trial Registration Number:
NCT00327691 (TNT); NCT00327418 (CARDS); NCT00159835 (IDEAL).
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pre-Procedural Guidelines for Assessing Blood Pressure
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT